Latest return on equity
Telomir Pharmaceuticals Return on equity
Direct answer
Telomir Pharmaceuticals's return on equity is -213.1%.
The verified market snapshot reports -213.1%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 6, 2026.
Get free Telomir Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -213.1%
Explore related company data
View Telomir Pharmaceuticals's market capitalizationView Telomir Pharmaceuticals's price-to-book ratioView Telomir Pharmaceuticals's dividend yieldView Telomir Pharmaceuticals's 52-week price rangeView Telomir Pharmaceuticals's profit marginView Telomir Pharmaceuticals's debt-to-equity ratioView all Telomir Pharmaceuticals key metricsReturn to Telomir Pharmaceuticals profile